These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941 [TBL] [Abstract][Full Text] [Related]
24. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)]. Slobodina GA Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846 [TBL] [Abstract][Full Text] [Related]
25. A study of the response of the leukopenia of rheumatoid arthritis to gold salt therapy. Mastaglia GL; Owen ET J Rheumatol; 1981; 8(4):658-60. PubMed ID: 6795350 [TBL] [Abstract][Full Text] [Related]
30. Thrombocytopenia associated with gold therapy. Observations on the mechanism of platelet destruction. Levin HA; McMillan R; Tavassoli M; Longmire RL; Yelenosky R; Sacks PV Am J Med; 1975 Aug; 59(2):274-80. PubMed ID: 808125 [TBL] [Abstract][Full Text] [Related]
31. Clozapine-induced blood dyscrasias in Saudi Arab patients. Abanmy NO; Al-Jaloud A; Al-Jabr A; Al-Ruwaisan R; Al-Saeed W; Fatani S Int J Clin Pharm; 2014 Aug; 36(4):815-20. PubMed ID: 24917217 [TBL] [Abstract][Full Text] [Related]
32. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
33. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Pullar T; Hunter JA; Capell HA Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117 [TBL] [Abstract][Full Text] [Related]
34. [Bone marrow aplasia and gold salts. Review of the literature apropos of 2 cases]. Pérez MC; Gómez Casares MT; Mataix R; Campo C; Jiménez S; Malcorra JJ Rev Clin Esp; 1994 Jul; 194(7):540-2. PubMed ID: 7938822 [TBL] [Abstract][Full Text] [Related]
35. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate. McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454 [TBL] [Abstract][Full Text] [Related]
36. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis. Bretza J; Wells I; Novey HS Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306 [TBL] [Abstract][Full Text] [Related]
37. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate. van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762 [TBL] [Abstract][Full Text] [Related]
38. [Side effects of gold salt therapy in patients with rheumatoid arthritis]. Vlak T; Jajić I Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149 [TBL] [Abstract][Full Text] [Related]
39. Gold-induced immune thrombocytopenia in the dog. Bloom JC; Blackmer SA; Bugelski PJ; Sowinski JM; Saunders LZ Vet Pathol; 1985 Sep; 22(5):492-9. PubMed ID: 3931338 [TBL] [Abstract][Full Text] [Related]